SCHEMBL7985682

SCHEMBL7985682

NC(=O)c1c(NC(=O)c2ccncc2)ncn1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
KDM4E B2RXH2 1/20 0.46
CCNC P24863 1/20 0.46
CDK8 P49336 1/20 0.46
MAPT P10636 2/20 0.43
RAB9A P51151 1/20 0.43
POLB P06746 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
RXFP1 Q9HBX9 1/20 0.42
JAK2 O60674 1/20 0.42
TYK2 P29597 1/20 0.42
KCNK3 O14649 1/20 0.41
HSD17B13 Q7Z5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7975241 0.93 GAA (0.50) GAAPKMTSHRSMN1; SMN2RAB9A
SCHEMBL7986413 0.89 HTT (0.52) TSHRHTTSMN1; SMN2RAB9AALDH1A1
SCHEMBL7988029 0.88 IDO1 (0.47) GAAPKMTSHRSMN1; SMN2RAB9A
SCHEMBL7985255 0.87 ALDH1A1 (0.51) GAAPKMTSHRHTTSMN1; SMN2
SCHEMBL7985500 0.87 NR1H4 (0.48) SMN1; SMN2KDM4EMAPTRAB9AALDH1A1
SCHEMBL7974581 0.86 LMNA (0.51) GAAPKMTSHRHTTSMN1; SMN2
SCHEMBL7985506 0.86 GAA (0.48) GAAPKMTSHRHTTSMN1; SMN2
SCHEMBL7984668 0.85 POLB (0.49) SMN1; SMN2KDM4EMAPTRAB9APOLB
SCHEMBL7973841 0.85 RAB9A (0.47) GAAPKMTSHRRAB9AMEN1
SCHEMBL7974040 0.84 KDM4E (0.51) GAAPKMTSHRKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed